Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Myelodysplastic-Myeloproliferative Diseases × idelalisib × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 21 Lymphoma, Follicular 9 Waldenstrom Macroglobulinemia 5 Lymphoma, B-Cell, Marginal Zone 5 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Leukemia 3 Lymphoma, Mantle-Cell 2 Lymphoma, B-Cell 2 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoid Malignancies 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Hodgkin Disease 1 Hematologic Diseases 1 Carcinoma, Non-Small-Cell Lung 1 B-cell Malignancies 1

Interventions

fludarabine phosphate 14 Cyclophosphamide 13 Peripheral Blood Stem Cell Transplantation 12 Whole-Body Irradiation 11 Busulfan 11 Mycophenolic Acid 10 Tacrolimus 9 Methotrexate 8 Cyclosporine 8 Antilymphocyte Serum 8 Etoposide 7 Melphalan 5 Cytarabine 5 Cyclosporins 5 Sirolimus 4 Radiotherapy 4 Rituximab 3 Filgrastim 3 Cord Blood Stem Cell Transplantation 3 thymoglobulin 2 ruxolitinib 2 Granulocyte Colony-Stimulating Factor 2 Flow Cytometry 2 Carmustine 2 Carboplatin 2 veliparib 1 vatalanib 1 treosulfan 1 sargramostim 1 rasburicase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡